(Q38431094)

English

Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group

scientific article published on August 2007

Statements

Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group (English)
Southwest Oncology Group
Christopher W Ryan
Bryan H Goldman
Primo N Lara
Philip C Mack
Tomasz M Beer
Catherine M Tangen
Dianne Lemmon
Chong-Xian Pan
Harry A Drabkin
E David Crawford
1 August 2007
3296-3301

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit